Progenics Pharmaceuticals Presents Updated Data From Phase 1 Study of …

Published February 14, 2013

Progenics Pharmaceuticals Presents Updated Data From Phase 1 Study of …

Filed under: Drug Treatment Help Seattle

PSMA ADC comprises a fully human monoclonal antibody selectively targeting PSMA linked to a chemotherapeutic drug. Using technology licensed from Seattle Genetics, Inc., the PSMA antibody is linked to monomethyl auristatin E, a compound that inhibits …
Read more on GlobeNewswire (press release)

Mental illness rates rise in youth facilities

Filed under: Drug Treatment Help Seattle

It surpassed the rate of similarly situated young offenders receiving drug and alcohol abuse treatment. "That gets worse as it goes along," said Nancy Arrigona, director of research for the Juvenile Justice Department, in an interview outside the hearing.
Read more on Seattle Post Intelligencer